Authors:
Ferrin, I
Rabinowitz, D
Schaefer, B
Snyder, J
Ellman, N
Vicente, B
Rengstorf, A
Depoy, D
Salim, S
Andrews, P
Bailyn, C
Baltay, C
Briceno, C
Coppi, P
Deng, M
Emmet, W
Oemler, A
Sabbey, C
Shin, J
Sofia, S
van Altena, W
Vivas, K
Abad, C
Bongiovanni, A
Bruzual, G
Della Prugna, F
Herrera, D
Magris, G
Mateu, J
Pacheco, R
Sanchez, G
Sanchez, G
Schenner, H
Stock, J
Vieira, K
Fuenmayor, F
Hernandez, J
Naranjo, O
Rosenzweig, P
Secco, C
Spavieri, G
Gebhard, M
Honeycutt, K
Mufson, S
Musser, J
Pravdo, S
Helin, E
Lawrence, K
Citation: I. Ferrin et al., Discovery of the bright trans-Neptunian object 2000 EB173, ASTROPHYS J, 548(2), 2001, pp. L243-L247
Authors:
Patat, A
Rosenzweig, P
Enslen, M
Trocherie, S
Miget, N
Bozon, MC
Allain, H
Gandon, JM
Citation: A. Patat et al., Effects of a new slow release formulation of caffeine on EEG, psychomotor and cognitive functions in sleep-deprived subjects, HUM PSYCHOP, 15(3), 2000, pp. 153-170
Authors:
Legangneux, E
McEwen, J
Wesnes, KA
Bergougnan, L
Miget, N
Canal, M
L'Heritier, C
Pinquier, JL
Rosenzweig, P
Citation: E. Legangneux et al., The acute effects of amisulpride (50 mg and 200 mg) and haloperidol (2 mg)on cognitive function in healthy elderly volunteers, J PSYCHOPH, 14(2), 2000, pp. 164-171
Citation: Aa. Ferro et P. Rosenzweig, The intermediate-band approach to the surface-brightness method for Cepheid radii and distance determination, M NOT R AST, 315(2), 2000, pp. 296-306
Authors:
Deschamps, C
Dubruc, C
Mentre, F
Rosenzweig, P
Citation: C. Deschamps et al., Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model, CLIN PHARM, 68(6), 2000, pp. 647-657
Citation: P. Rosenzweig et A. Patat, Lack of behavioural toxicity of mizolastine: a review of the clinical pharmacology studies, CLIN EXP AL, 29, 1999, pp. 156-162
Authors:
Patat, A
Rosenzweig, P
Miget, N
Allain, H
Gandon, JM
Citation: A. Patat et al., Effects of 50mg amisulpride on EEG, psychomotor and cognitive functions inhealthy sleep-deprived subjects, FUN CL PHAR, 13(5), 1999, pp. 582-594
Citation: P. Rosenzweig et al., Transaminase elevation on placebo during Phase I trials: prevalence and significance, BR J CL PH, 48(1), 1999, pp. 19-23
Authors:
Chaufour, S
Caplain, H
Lilienthal, N
L'Heritier, C
Deschamps, C
Dubruc, C
Rosenzweig, P
Citation: S. Chaufour et al., Study of cardiac repolarization in healthy volunteers performed with mizolastine, a new H-1-receptor antagonist, BR J CL PH, 47(5), 1999, pp. 515-520
Authors:
Patat, A
Chaufour, S
Gandon, JM
Allain, H
Rosenzweig, P
Citation: A. Patat et al., Safety and pharmacodynamics of single ascending doses of SL34.0026, a new reversible and selective MAO-B inhibitor in healthy subjects, BR J CL PH, 47(5), 1999, pp. 584-585
Authors:
Ramaekers, JG
Louwerens, JW
Muntjewerff, ND
Milius, H
de Bie, A
Rosenzweig, P
Patat, A
O'Hanlon, JF
Citation: Jg. Ramaekers et al., Psychomotor, cognitive, extrapyramidal, and affective functions of healthyvolunteers during treatment with an atypical (amisulpride) and a classic (haloperidol) antipsychotic, J CL PSYCH, 19(3), 1999, pp. 209-221
Authors:
Schaefer, BE
Snyder, JA
Hernandez, J
Roscherr, B
Deng, M
Ellman, N
Bailyn, C
Rengstorf, A
Smith, D
Levine, A
Barthelmy, S
Butterworth, P
Hurley, K
Cline, T
Meegan, C
Kouveliotou, C
Kippen, RM
Park, HS
Williams, GG
Porrata, R
Bionta, R
Hartmann, D
Band, D
Frail, D
Kulkarni, S
Bloom, J
Djorgovski, S
Sadava, D
Chaffee, F
Harris, F
Abad, C
Adams, B
Andrews, P
Baltay, C
Bongiovanni, A
Briceno, C
Bruzual, G
Coppi, P
Della Prugna, F
Dubuc, A
Emmet, W
Ferrin, I
Fuenmayor, F
Gebhard, M
Herrera, D
Honeycutt, K
Magris, G
Mateu, J
Muffson, S
Musser, J
Naranjo, O
Oemler, A
Pacheco, R
Paredes, G
Rengel, M
Romero, L
Rosenzweig, P
Sabbey, C
Sanchez, G
Sanchez, G
Schenner, H
Shin, J
Sinnott, J
Sofia, S
Stock, J
Suarez, J
Telleria, D
Vicente, B
Vieira, K
Vivas, K
Citation: Be. Schaefer et al., Discovery of the optical transient of GRB 990308, ASTROPHYS J, 524(2), 1999, pp. L103-L106